Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Shilpa Medicare Ltd. Call Transcript 2025

Nov 5, 2025

62243_rns_2025-11-05_2d4a1afe-a2fe-4da0-9cd2-b9e481529d91.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [143 x 42] intentionally omitted <==

Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: [email protected], Web: www.vbshilpa.com CIN: L85110KA1987PLC008739

Date: 5[th] November 2025

To,

Corporate Relationship Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block Dalal Street, Fort, Bandra Kurla Complex, Bandra (E) Mumbai-400 001 Mumbai-400 051

Dear Madam/Sir,

Sub: Analysts/Investors call Ref: Stock Code: NSE: SHILPAMED/BSE-530549

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Q2- FY26 Earnings Conference Call, which is to be held on Monday, November 17, 2025, at 11.00 hrs.

A copy of this intimation is also being made available at:

We request you to take the above information on record.

Thanking you.

Yours faithfully, For Shilpa Medicare Limited

Digitally signed by RITU RITU TIWARY TIWARY Date: 2025.11.05 17:23:32 +05'30'

Ritu Tiwary Company Secretary

==> picture [143 x 48] intentionally omitted <==

Shilpa Medicare Limited 2QFY26 Earnings Conference Call

Shilpa Medicare Limited (BSE:530549; NSE: SHILPAMED) will announce its results for the second quarter ended September 30, 2025 on Thursday, November 13, 2025 .

The management of the Company will host its earnings call on Monday, November 17, 2025 at 11:00 hrs .

Details of Earnings Conference Call Details of Earnings Conference Call
Day/Date Monday, November 17, 2025
Time 11:00 hrs
Universal Access +91 22 6280 1130+91 22 7115 8031
The number listed above is universally accessible from all networks and all countries
International Toll-Free Numbers
USAUKSingaporeHong Kong 18667462133080810115738001012045800964448
DiamondPassLink Click hereto join with DiamondPass(No Wait Time)
Participants are requested to dial-in 10 minutes before the scheduled time

About Shilpa Medicare Limited (SML)

Shilpa Medicare Limited (SML) is an integrated pharmaceutical group with business interests in niche Oncology & Non-oncology APIs, Peptides, Polymers, differentiated finished dosage formulations including orally dispersible films & transdermal patches along with carefully crafted biological portfolio. The company also provides end-to-end CDMO services to global pharmaceutical companies across all its business segments based on its strong R&D and manufacturing capabilities backed by four R&D units and seven manufacturing facilities.

For more information, visit www.vbshilpa.com

For further details, please get in touch with

Shilpa Medicare Ltd Monish Shah E: [email protected]